6:12 PM
May 04, 2009
 |  BC Extra  |  Company News

FDA panel to discuss Arzerra

Genmab A/S (CSE:GEN) said FDA's Oncologic Drugs Advisory Committee will meet May 29 to discuss a BLA...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >